Sr. Specialist, Manufacturing Systems Engineer II, MS&T MSEO at Bristol-Myers Squibb

Summit, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Self-directed, goal-oriented, flexible, able to work efficiently across multiple projects
Enthusiastic and innovative
Good understanding of good manufacturing practices (GMP) and technologies to support Site Manufacturing Teams
Works under the guidance of lead team members
Ability to collaborate with local (site) Business Process Owners, Global MS&T, Global IT, Cell Therapy Network subject matter experts, MSEO Operations support, Site IT, and resources supporting boundary systems

Responsibilities

Provide technical direction and expertise across Site teams (Manufacturing, Quality, Supply Chain, Shared Services, etc.) to support and improve capacity, quality, and cost or to establish root cause
Work closely with end users/process owners and subject matter experts to maintain service level expectations across all functions and site systems
Provide on-the-floor or remote process support for ongoing manufacturing activities when needed
Participate in delivering critical improvements across the manufacturing network through digital technology (e.g., EBR) updates and technical insight
Provide MES product impact assessments to support change management, investigations, and product release
Develop inputs into electronic batch record/process automation technologies to advance digital manufacturing strategy
Lead or assist in designing, testing, and maintaining Electronic Batch Records and related manufacturing data, including specifications, process parameters, recipes, routings, formulas, process instructions, and process variables
Ensure Recipes/MES are configured for intended use per business requirements and applicable procedures throughout the recipes and MES system lifecycle from design to implementation
Support consistent execution of MES recipe modifications, change controls, and adherence to governing documents related to change management
Support lifecycle management project implementation at a site level to accomplish drug product harmonization across sites

Skills

MES

Manufacturing Execution Systems

Cell Therapy

Change Management

Continuous Improvement

GMP

Manufacturing Systems Engineering

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free